Overview
Lung cancer care is advancing rapidly — with new treatments, technologies and research reshaping patient outcomes. This study day offers a rare opportunity to hear directly from specialists across multiple disciplines who are driving these changes.
You’ll gain clear, practical insight grounded in evidence and real clinical experience, helping you strengthen your understanding of complex pathways and improve your ability to support patients at every stage of their journey. Whether you work clinically or in a supporting role, this programme provides essential knowledge for delivering safe, effective and compassionate lung cancer care.
Key information
Delivery type
Face-to-face or online study day (6-month on-demand access included)
Delivery style
Lectures, case studies, videos and multidisciplinary panel discussions
Duration
1 full day
Experience level
All levels welcome
Cost
- Onsite: £105
- Virtual: £105
- Low- and Middle-Income Countries (LMIC): £50
- Student: £70
- Offer 5 for 4 onsite and virtual: £84
- Pharma and industry: £200
What to expect
Lung cancer remains one of the most common and challenging cancers worldwide — and managing it effectively requires up-to-date knowledge, strong multidisciplinary collaboration and a deep understanding of fast-moving treatment innovations.
This one-day study day brings together expert clinicians from across oncology, respiratory medicine, radiology, pathology and surgery to explore the rapidly evolving landscape of lung cancer diagnosis and care. You’ll gain insight into screening approaches, staging, toxicity management, symptom control and the expanding world of targeted therapies and immunotherapies.
Through lectures, case discussions and panel conversations, you’ll explore how new diagnostics, clinical trials and research breakthroughs are transforming pathways for patients with NSCLC and SCLC. The course also highlights the importance of holistic, patient-centred care — including non-pharmacological approaches to symptom management and long-term survivorship considerations.
On-demand access after the event allows you to revisit sessions and learn at your own pace.
Learning outcomes
By the end of this study day, you will be able to:
- Understand current approaches to lung cancer screening and early detection
- Describe evolving treatment options for NSCLC and SCLC
- Recognise and manage toxicities associated with modern lung cancer therapies
- Apply non-pharmacological strategies for challenging lung cancer symptoms
- Understand the role of clinical trials and emerging research in shaping treatment pathways
- Support patient-centred care through multidisciplinary collaboration
Who is it for?
Ideal for professionals involved in lung cancer care, including:
- Oncologists
- Respiratory Physicians
- Thoracic Surgeons
- Specialist Nurses
- Radiologists
- Pathologists
- Allied Health Professionals
- Any healthcare professional supporting lung cancer pathways
How to book/learn more
You can book this course on Eventbrite.
Not ready to book? Find out more
What's new?
The Christie Institute news-
Read more about The beginning of an international partnership between The Christie and the National Cancer Institute of UkraineThe beginning of an international partnership between The Christie and the National Cancer Institute of Ukraine
The Christie Institute for Cancer Education has welcomed international colleagues from the National Cancer Institute of Ukraine (UNCI) as part of a new education partnership focused on bilateral sharing of knowledge.
-
Read more about International newsletter 2025International newsletter 2025
We are delighted to announce the release of our International Newsletter which will give you an insight into the work we are doing to bring life-enhancing education to an international audience.
-
Read more about Cadaveric Hands-On Surgery Courses – January 2026Cadaveric Hands-On Surgery Courses – January 2026
Our Surgical Team here at The Christie are bringing a unique opportunity for qualified surgeons, trainees and early career surgeons to experience a hands-on cadaveric surgery course this coming January.